Table 3.
All patients (n = 4,366) | ||
---|---|---|
Variable | HR (95% CI) | P* |
Categorical BMI (overall) | 0.0017 | |
Underweight vs normal | 1.24 (1.03–1.50) | 0.0258† |
Overweight vs normal | 0.90 (0.80–1.00) | 0.0500† |
Class 1 obese vs normal | 1.07 (0.93–1.23) | 0.3717† |
Class 2,3 obese vs normal | 1.19 (0.98–1.45) | 0.0805† |
Age | 1.01 (1.01–1.02) | <0.0001 |
Stage (II vs III) | 0.47 (0.41–0.53) | <0.0001 |
Treatment (effective vs control/ineffective) | 0.72 (0.62–0.85) | <0.0001 |
Gender (men vs women) | 1.15 (1.04–1.26) | 0.0045 |
Men (n = 2,268) | ||
Variable | HR (95% CI) | P* |
Categorical BMI (overall) | 0.0021 | |
Underweight vs normal | 1.14 (0.81–1.61) | 0.4474† |
Overweight vs normal | 0.82 (0.71–0.95) | 0.0063† |
Class 1 obese vs normal | 0.94 (0.78–1.15) | 0.5599† |
Class 2,3 obese vs normal | 1.35 (1.02–1.79) | 0.0391† |
Age | 1.01 (1.01–1.02) | <0.0001 |
Stage (II vs III) | 0.51 (0.43–0.61) | <0.0001 |
Treatment (effective vs control/ineffective) | 0.64 (0.51–0.80) | <0.0001 |
Women (n = 2,098) | ||
Variable | HR (95% CI) | P* |
Categorical BMI (overall) | 0.0674 | |
Underweight vs normal | 1.32 (1.05–1.67) | 0.0194† |
Overweight vs normal | 1.01 (0.85–1.19) | 0.9366† |
Class 1 obese vs normal | 1.24 (1.01–1.53) | 0.0447† |
Class 2,3 obese vs normal | 1.11 (0.84–1.45) | 0.4651† |
Age (1-y increase) | 1.01 (1.00–1.02) | 0.0052 |
Stage (II vs III) | 0.41 (0.34–0.51) | <0.0001 |
Treatment (effective vs control/ineffective) | 0.83 (0.66–1.04) | 0.0948 |
Likelihood ratio P value after stratifying by study.
Wald Χ2 P value.